Stock Scheduled Dividends 11/01/2017 "Sch. Ex Date"

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
121
Stock Scheduled Dividends 11/01/2017

"Sch. Ex Date" Symbol Company Name Security Type Venue Type Cash Amt. Stock Amt. Freq.
Nov 2, 2017 BCBP BCB Bancorp, Inc. Common Stock Nasdaq Cash Dividend 0.14 0 Quarterly
Nov 2, 2017 BKEP Blueknight Energy Partners L.P., L.L.C Units Nasdaq Cash Dividend 0.145 0 Quarterly
Nov 2, 2017 BKEPP Blueknight Energy Partners L.P., L.L.C Common Stock Nasdaq Cash Dividend 0.17875 0 Quarterly
Nov 2, 2017 BLGPY Boart Longyear Group American Depository Receipts Grey Market Cash Dividend 0.0239
Nov 2, 2017 BMRC Bank of Marin Bancorp Common Stock Nasdaq Cash Dividend 0.29 0 Quarterly
Nov 2, 2017 BPFH Boston Private Financial Holdings, Inc. Common Stock Nasdaq Cash Dividend 0.11 0 Quarterly
Nov 2, 2017 BRKL Brookline Bancorp, Inc. Common Stock Nasdaq Cash Dividend 0.09 0 Quarterly
Nov 2, 2017 CAIXY Caixabank SA American Depository Receipts OTC Link Cash Dividend 0.01956
Nov 2, 2017 CBF Capital Bank Financial Corp. Common Stock Nasdaq Cash Dividend 0.12 0 Quarterly
Nov 2, 2017 CCYY Clarion County Community Bank (PA) Common Stock OTC Link Cash Dividend 0.12
Nov 2, 2017 CFFN Capitol Federal Financial, Inc. Common Stock Nasdaq Cash Dividend 0.085 0 Quarterly
Nov 2, 2017 CPLP Capital Product Partners L.P. Units Nasdaq Cash Dividend 0.08 0 Quarterly
Nov 2, 2017 CVCY Central Valley Community Bancorp Common Stock Nasdaq Cash Dividend 0.06 0 Quarterly
Nov 2, 2017 DNLMY Dunelm Group PLC American Depository Receipts OTC Link Cash Dividend 0.23034
Nov 2, 2017 EFSI Eagle Financial Services, Inc. Common Stock OTC Link Cash Dividend 0.22
Nov 2, 2017 FBMS First Bancshares, Inc. (The) Common Stock Nasdaq Cash Dividend 0.0375 0 Quarterly
Nov 2, 2017 FCBC First Community Bancshares, Inc. Common Stock Nasdaq Cash Dividend 0.18 0 Quarterly
Nov 2, 2017 FRAF Franklin Financial Services Corp. Common Stock OTC Link Cash Dividend 0.24
Nov 2, 2017 GPP Green Plains Partners LP Common Stock Nasdaq Cash Dividend 0.46 0 Quarterly
Nov 2, 2017 HSII Heidrick & Struggles International, Inc. Common Stock Nasdaq Cash Dividend 0.13 0 Quarterly
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading